Peter Langecker - Net Worth and Insider Trading
Peter Langecker Net Worth
The estimated net worth of Peter Langecker is at least $111 dollars as of 2024-09-20. Peter Langecker is the Chief Medical Officer of Durect Corp and owns about 80 shares of Durect Corp (DRRX) stock worth over $111. Details can be seen in Peter Langecker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter Langecker has not made any transactions after 2006-05-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter Langecker
Peter Langecker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Langecker owns 3 companies in total, including Oncotelic Therapeutics Inc (OTLC) , Durect Corp (DRRX) , and Cyclacel Pharmaceuticals Inc (CYCC) .
Click here to see the complete history of Peter Langecker’s form 4 insider trades.
Insider Ownership Summary of Peter Langecker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OTLC | Oncotelic Therapeutics Inc | 2009-06-29 | Chief Development Officer |
| DRRX | Durect Corp | 2006-05-01 | Chief Medical Officer |
| CYCC | Cyclacel Pharmaceuticals Inc | 2004-06-22 | director |
Peter Langecker Latest Holdings Summary
Peter Langecker currently owns a total of 1 stock. Peter Langecker owns 80 shares of Durect Corp (DRRX) as of May 1, 2006, with a value of $111.
Latest Holdings of Peter Langecker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRRX | Durect Corp | 2006-05-01 | 80 | 1.39 | 111 |
Holding Weightings of Peter Langecker
Peter Langecker Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Langecker has made a total of 0 transactions in Durect Corp (DRRX) over the past 5 years. The most-recent trade in Durect Corp is the sale of 0 shares on May 1, 2006, which brought Peter Langecker around $0.
Insider Trading History of Peter Langecker
- 1
Peter Langecker Trading Performance
Peter Langecker Ownership Network
Peter Langecker Owned Company Details
What does Oncotelic Therapeutics Inc do?
Who are the key executives at Oncotelic Therapeutics Inc?
Peter Langecker is the Chief Development Officer of Oncotelic Therapeutics Inc. Other key executives at Oncotelic Therapeutics Inc include CHIEF EXECUTIVE OFFICER Vuong Trieu , CHIEF BUSINESS OFFICER Saran Saund , and CHIEF FINANCIAL OFFICER Amit B. Shah .
Oncotelic Therapeutics Inc (OTLC) Insider Trades Summary
Over the past 18 months, Peter Langecker made no insider transaction in Oncotelic Therapeutics Inc (OTLC). Other recent insider transactions involving Oncotelic Therapeutics Inc (OTLC) include a net purchase of 1,326,888 shares made by Vuong Trieu ,
In summary, during the past 3 months, insiders sold 0 shares of Oncotelic Therapeutics Inc (OTLC) in total and bought 500,000 shares, with a net purchase of 500,000 shares. During the past 18 months, 0 shares of Oncotelic Therapeutics Inc (OTLC) were sold and 1,326,888 shares were bought by its insiders, resulting in a net purchase of 1,326,888 shares.
Oncotelic Therapeutics Inc (OTLC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncotelic Therapeutics Inc Insider Transactions
Peter Langecker Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Langecker. You might contact Peter Langecker via mailing address: C/o Intarcia Therapeutics, Inc., 2000 Powell St., Suite 1640, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
